IGF-1 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-04-27. Numbers and descriptions here follow the published literature rather than marketing material.
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存，可维持较长时间的稳定。复溶后稳定性明显下降，溶液中的肽链易发生水解、氧化与聚集，通常需冷藏并在短期内用完。反复冻融会加速聚集与降解，建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率，需要按具体实验条件验证。
研究用与临床用材料的标准并不相同。质量控制通常覆盖纯度、残留溶剂、反离子含量、微生物限度与内毒素水平，各项均有对应检测方法。随货文件应包含批号、检测项目、方法与结果，使数据可以追溯。核验时应关注纯度是否按主峰面积计算、杂质是否已定性、方法是否经过验证，这些信息决定结果能否被外部重复。
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
Stability testing examines how the molecule changes under controlled stress. Thermal stress, light exposure, and extremes of pH are applied separately so that each degradation route can be attributed to a specific cause. The main observed changes are oxidation, deamidation, and aggregation into dimers or higher-order species. Accelerated studies at elevated temperature are used to estimate behavior over longer periods, though such extrapolation carries uncertainty. For a lyophilized powder, residual moisture and the choice of bulking agent strongly influence how quickly these changes appear.
| 性质 | 取值 | 备注 |
|---|---|---|
| 外观 | 白色至类白色冻干粉 | 常见形态 |
| 溶解性 | 易溶于水与水性缓冲液 | 多肽类通性 |
| 典型储存温度 | -20°C 或更低 | 干燥避光 |
| 常用纯度方法 | 反相高效液相色谱 | 214 nm 紫外检测 |
| 常用分子量确认 | 质谱 | 电喷雾或激光解吸 |
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from truncated or oxidized forms. Mass spectrometry confirms the expected molecular weight, and peptide mapping after enzymatic digestion verifies the amino acid sequence. Water content is measured because residual moisture affects stability, and tests for aggregates or particulates are standard for injectable peptides. Circular dichroism can indicate whether the molecule has adopted an unexpected secondary structure in solution.
Research supply is often accompanied by a certificate of analysis listing chromatographic purity, mass confirmation, and storage conditions. Laboratories compare that document with an independent test when material is intended for bench work, since certificates describe a batch rather than an individual vial. Published studies usually state the source and purity of the peptide because small differences in purity can shift measured activity. Full analytical validation is rarely reported, which leaves batch-to-batch comparability an open question.
The peptide is supplied as a lyophilized powder in single-use vials and is normally kept refrigerated between two and eight degrees Celsius, protected from light. Once dissolved, the solution is handled carefully because peptide bonds and the acyl modification can degrade under warm or alkaline conditions. Vials are inspected for cracks, and the powder is checked for color and uniformity before handling. Temperature excursions during shipping are a frequent reason for quality questions.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
Questions remain about how much of the observed fat reduction reflects direct GHRH-receptor signaling versus the downstream growth hormone and IGF-1 surge. It is also unclear whether the compound produces meaningful benefit in populations without lipodystrophy, since trials in cognitive impairment did not reach their stated goals. Long-term effects on glucose metabolism and on cardiovascular outcomes are not fully characterized. Published work generally describes effects on surrogate markers rather than on hard clinical endpoints, and independent replication of some findings is limited.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
=== Ultraviolet lens === A hyperlens is a real-time super-resolution lens that can transform evanescent waves into propagating waves and thus break the diffraction limit. In 2016 a hyperlens based on dielectric layered graphene and h-boron nitride (h-BN) can surpass metal designs. Based on its anisotropic properties, flat and cylindrical hyperlenses were numerically verified with layered graphene at 1200 THz and layered h-BN at 1400 THz, respectively. In 2016 a 1-nm thick graphene microlens that can image objects the size of a single bacterium. The lens was created by spraying a sheet of graphene oxide solution, then molding the lens using a laser beam. It can resolve objects as small as 200 nanometers, and see into the near infrared. It breaks the diffraction limit and achieve a focal length less than half the wavelength of light. Possible applications include thermal imaging for mobile phones, endoscopes, nanosatellites and photonic chips in supercomputers and superfast broadband distribution.
== Awards == Vincent du Vigneaud Award for Excellence in Peptide Science (2000) American Chemical Society's Ralph F. Hirschmann Award in Peptide Chemistry (2004) Bruce Merrifield Award (2005) Fellow of the American Association of Pharmaceutical Scientists (2006) Dan K. Richardson Entrepreneurship Program's 2011 Entrepreneur of the Year
Muscle tissue comprises cardiac, skeletal, and smooth muscle. Smooth muscles control the flow of substances within the lumens of hollow organs, and are not consciously controlled. In the small intestine, smooth muscle contraction is characterised by peristalsis. Skeletal muscles are attached to bones and arranged in opposing groups around joints. Skeletal muscles and cardiac muscles have striations, unlike smooth muscle. Only skeletal and smooth muscles are part of the musculoskeletal system and can move the body. Cardiac muscles are found in the heart and are used only to circulate blood; like the smooth muscles, these muscles are not under conscious control. Nervous tissue comprises neuroglia, which provide structural and metabolic support, and neurons, which send signals in the form of electrochemical impulses traveling along axons. Bundles of axons are known as nerve tracts and neural pathways. Impulses can be directly transmitted to neighbouring cells through electrical synapses or cause chemicals called neurotransmitters to be released at chemical synapses. The CNS includes astrocytes (-cyte, 'cell'; Greek κύτος (kútos), a hollow, vessel), oligodendrocytes, ependyma, and radial glia; the PNS includes Schwann cells, satellite glia, and enteric glia. Astrocytes are star-shaped glial cells that have been observed to turn into neurons by virtue of their pluripotency. Microglia are specialized macrophages capable of phagocytosis that protect neurons of the central nervous system.
Sources: en.wikipedia.org
== History == Evidence for periostitis found in the fossil record is studied by paleopathologists, specialists in ancient disease and injury. Periostitis has been seen in the late Cretaceous-Eocene crocodile Borealosuchus formidabilis, once known as Leidyosuchus. In one study, periostitis was the most common pathology in this species, with 134 instances of the condition out of 7,154 bones the scientists examined showing evidence for the condition. Periostitis has also been documented in dinosaurs, including a forelimb referred to as the long-necked Camarasaurus grandis, as well as the shoulder blade of a horned dinosaur.
23 May – Sunak confirms that no asylum seekers will be sent to Rwanda before the general election under UK government deportation plans. Nigel Farage, founder of Reform UK, confirms he will not stand as a candidate in the upcoming general election. Police Scotland announces that it has submitted a "standard prosecution report" concerning its investigation into SNP finances to the Crown Office and Procurator Fiscal Service. First Minister of Scotland John Swinney announces he will not accept a parliamentary committee ruling to exclude Michael Matheson from Holyrood for 27 days over his £11,000 iPad charges bill, saying the decision is "prejudiced" due to the involvement of a Conservative MSP who previously made comments about Matheson. 24 May – Sir John Redwood, MP for Wokingham, announces he will not contest the next election. Former Education Secretary Michael Gove announces he will not stand for parliament again at the next election. Junior health minister Andrea Leadsom announces she will not contest the next election. Craig Mackinlay decides he will not contest the new parliamentary seat of Thanet East after what he describes as "36 hours of intense soul searching" following the announcement of the election and his feeling that the work schedule would be too much to deal with while he continues to recover from sepsis. Greg Clark, MP for Tunbridge Wells, announces he will not contest the next general election.
As noted by Carl Johnson in Ambio, "Exposures of a large population in the Denver area to plutonium and other radionuclides in the exhaust plumes from the plant date back to 1953." Weapons production at the Rocky Flats plant was halted after a combined FBI and EPA raid in 1989 and years of protests. The plant has since been shut down, with its buildings demolished and completely removed from the site. In the U.S., some plutonium extracted from dismantled nuclear weapons is melted to form glass logs of plutonium oxide that weigh two tonnes. The glass is made of borosilicates mixed with cadmium and gadolinium. These logs are planned to be encased in stainless steel and stored as much as 4 km (2 mi) underground in bore holes that will be backfilled with concrete. The U.S. planned to store plutonium in this way at the Yucca Mountain nuclear waste repository, which is about 100 miles (160 km) north-east of Las Vegas, Nevada. On March 5, 2009, Energy Secretary Steven Chu told a Senate hearing "the Yucca Mountain site no longer was viewed as an option for storing reactor waste". Starting in 1999, military-generated nuclear waste is being entombed at the Waste Isolation Pilot Plant in New Mexico. In a Presidential Memorandum dated January 29, 2010, President Obama established the Blue Ribbon Commission on America's Nuclear Future. In their final report the Commission put forth recommendations for developing a comprehensive strategy to pursue, including:
Gender-affirming hormone therapy (GAHT), also known as hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity. This form of hormone therapy is given as one of two types, based on whether the goal of treatment is masculinization or feminization:
Sources: en.wikipedia.org
多肽在反相柱上按疏水性差异分离，能有效区分主峰、缺失序列片段与氧化产物。配合紫外检测可获得可量化的纯度百分比，是肽类分析的常规手段。
一般建议密封、避光、干燥，并在 -20°C 或更低温度下存放。温度波动和湿气是主要风险，长期存放应避免反复开启容器。
没有统一答案，取决于缓冲液、浓度、pH 与储存温度。多数做法是冷藏并在数天至数周内用完，具体期限需要通过稳定性实验确认。
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the standard technique for purity and content. Mass spectrometry provides orthogonal confirmation of identity. The two are normally used together rather than in isolation.